These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36810913)

  • 1. An intrinsic purine metabolite AICAR blocks lung tumour growth by targeting oncoprotein mucin 1.
    Aftab F; Rodriguez-Fuguet A; Silva L; Kobayashi IS; Sun J; Politi K; Levantini E; Zhang W; Kobayashi SS; Zhang WC
    Br J Cancer; 2023 May; 128(9):1647-1664. PubMed ID: 36810913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the oncogenic MUC1-C protein inhibits mutant EGFR-mediated signaling and survival in non-small cell lung cancer cells.
    Kharbanda A; Rajabi H; Jin C; Tchaicha J; Kikuchi E; Wong KK; Kufe D
    Clin Cancer Res; 2014 Nov; 20(21):5423-34. PubMed ID: 25189483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR Signaling.
    Takahashi S; Noro R; Seike M; Zeng C; Matsumoto M; Yoshikawa A; Nakamichi S; Sugano T; Hirao M; Matsuda K; Hamada M; Gemma A
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma.
    Xu H; Du Z; Li Z; Liu X; Li X; Zhang X; Ma J
    Ann Med; 2024 Dec; 56(1):2313671. PubMed ID: 38325364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1 contributes to goblet cell metaplasia and MUC5AC expression in response to cigarette smoke in vivo.
    Kato K; Chang EH; Chen Y; Lu W; Kim MM; Niihori M; Hecker L; Kim KC
    Am J Physiol Lung Cell Mol Physiol; 2020 Jul; 319(1):L82-L90. PubMed ID: 32401676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC1 regulates AKT signaling pathway by upregulating EGFR expression in ovarian cancer cells.
    Ma Q; Song J; Wang S; He N
    Pathol Res Pract; 2021 Aug; 224():153509. PubMed ID: 34118726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC1 stimulates EGFR expression and function in endometrial cancer.
    Engel BJ; Bowser JL; Broaddus RR; Carson DD
    Oncotarget; 2016 May; 7(22):32796-809. PubMed ID: 27092881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-21 guide and passenger strand regulation of adenylosuccinate lyase-mediated purine metabolism promotes transition to an EGFR-TKI-tolerant persister state.
    Zhang WC; Skiados N; Aftab F; Moreno C; Silva L; Corbilla PJA; Asara JM; Hata AN; Slack FJ
    Cancer Gene Ther; 2022 Dec; 29(12):1878-1894. PubMed ID: 35840668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner.
    Jin W; Liao X; Lv Y; Pang Z; Wang Y; Li Q; Liao Y; Ye Q; Chen G; Zhao K; Huang L
    Cell Death Dis; 2017 Aug; 8(8):e2980. PubMed ID: 28796259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of galectin-3 with MUC1 on cell surface promotes EGFR dimerization and activation in human epithelial cancer cells.
    Piyush T; Chacko AR; Sindrewicz P; Hilkens J; Rhodes JM; Yu LG
    Cell Death Differ; 2017 Nov; 24(11):1937-1947. PubMed ID: 28731466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1 regulates nuclear localization and function of the epidermal growth factor receptor.
    Bitler BG; Goverdhan A; Schroeder JA
    J Cell Sci; 2010 May; 123(Pt 10):1716-23. PubMed ID: 20406885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1 drives c-Met-dependent migration and scattering.
    Horm TM; Bitler BG; Broka DM; Louderbough JM; Schroeder JA
    Mol Cancer Res; 2012 Dec; 10(12):1544-54. PubMed ID: 23193156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular MUC1 peptides inhibit cancer progression.
    Bitler BG; Menzl I; Huerta CL; Sands B; Knowlton W; Chang A; Schroeder JA
    Clin Cancer Res; 2009 Jan; 15(1):100-9. PubMed ID: 19118037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting MUC1-C inhibits the AKT-S6K1-elF4A pathway regulating TIGAR translation in colorectal cancer.
    Ahmad R; Alam M; Hasegawa M; Uchida Y; Al-Obaid O; Kharbanda S; Kufe D
    Mol Cancer; 2017 Feb; 16(1):33. PubMed ID: 28153010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MUC1 induces the accumulation of Foxp3
    Zhang G; Zheng G; Zhang H; Qiu L
    Int Immunopharmacol; 2023 May; 118():110091. PubMed ID: 37018979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pivotal role of MUC1 glycosylation by cigarette smoke in modulating disruption of airway adherens junctions in vitro.
    Zhang L; Gallup M; Zlock L; Chen YT; Finkbeiner WE; McNamara NA
    J Pathol; 2014 Sep; 234(1):60-73. PubMed ID: 24838315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland.
    Schroeder JA; Thompson MC; Gardner MM; Gendler SJ
    J Biol Chem; 2001 Apr; 276(16):13057-64. PubMed ID: 11278868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.
    Guddo F; Giatromanolaki A; Koukourakis MI; Reina C; Vignola AM; Chlouverakis G; Hilkens J; Gatter KC; Harris AL; Bonsignore G
    J Clin Pathol; 1998 Sep; 51(9):667-71. PubMed ID: 9930070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance.
    Xu X; Wells A; Padilla MT; Kato K; Kim KC; Lin Y
    Carcinogenesis; 2014 Nov; 35(11):2457-66. PubMed ID: 25085901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane-tethered MUC1 mucin is phosphorylated by epidermal growth factor receptor in airway epithelial cells and associates with TLR5 to inhibit recruitment of MyD88.
    Kato K; Lillehoj EP; Park YS; Umehara T; Hoffman NE; Madesh M; Kim KC
    J Immunol; 2012 Feb; 188(4):2014-22. PubMed ID: 22250084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.